First Light Asset Management, LLC Centessa Pharmaceuticals PLC Transaction History
First Light Asset Management, LLC
- $1.02 Billion
- Q4 2024
A detailed history of First Light Asset Management, LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, First Light Asset Management, LLC holds 5,805,184 shares of CNTA stock, worth $96.5 Million. This represents 9.51% of its overall portfolio holdings.
Number of Shares
5,805,184
Previous 5,940,132
2.27%
Holding current value
$96.5 Million
Previous $95 Million
2.37%
% of portfolio
9.51%
Previous 8.27%
Shares
4 transactions
Others Institutions Holding CNTA
# of Institutions
118Shares Held
124MCall Options Held
7KPut Options Held
220K-
Medicxi Ventures Management (Jersey) LTD20MShares$332 Million73.44% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$166 Million99.89% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$161 Million5.81% of portfolio
-
Perceptive Advisors LLC New York, NY6.35MShares$106 Million3.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.36MShares$89.2 Million0.01% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.57B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...